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We investigated the presence of bullous pemphigoid anti-
bodies in bullous pemphigoid sera that are negative by stan-
dard indirect immunofluorescence. We incubated each of 
four indirect immunofluorescence-positive bullous pemphi-
goid sera, seven indirect immunofluorescence-negative 
bullous pemphigoid sera, one indirect immunofluorescence-
negative herpes gestationis serum, three indirect immuno-
fluorescence-positive epidermolysis bullosa acquisita sera, 
five indirect immunofluorescence-negative epidermolysis 
bullosa acquisita sera, and two normal human sera with fresh 
human skin explants in medium 199 at 4 0 C for 48 h. All 
bullous pemphigoid sera, herpes gestationis serum, and the 
three indirect immunofluorescence-positive epidermolysis 
bullosa acquisita sera had IgG that bound the basement mem-
O ur understanding of bullous pemphigoid (BP) has advanced remarkably during the past decade. The proposed hypothesis about the pathogenesis of BP lesions is the following [1]. Circulating BP immu-noglobulin G (IgG) binds the epidermal basement 
membrane zone (BMZ) in the lamina lucida and activates comple-
ment [2]. Chemotactic factors (complement components and mast 
cell components) attract eosinophils that digest the BMZ and lead to 
blister formation [1]. BP antigen is located in the hemidesmosome 
(HD) area within both the intracellular plaque as well as in the 
underlying (extracellular) lamina lucida. Antibody binding to he-
midesmosomes is readily demonstrable by standard indirect immu-
nofluorescence (II F) [3] and immunoelectron microscopy (using 
IIF-positive BP sera) [4-6] . Antibody binding to the lamina lucida 
is detected only with prolonged incubation of skin explants with 
IIF-positive BP sera under conditions similar to organ culture [5,7]. 
Most BP sera that are positive by IIF contain antibodies that identify 
a high - molecular weight epidermal protein (220- 240 kD) and/or 
a low-molecular weight epidermal protein (180 kD) by immunob-
lotting and immunoprecipitation [8 -11] . Recent molecular biol-
ogy studies suggest that the high - molecular weight BP antigen is 
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brane zone of skin explants with moderate to marked inten-
sity as demonstrated by immunofluorescence. Normal sera 
and indirect immunofluorescence-negative epidermolysis 
bullosa acquisita sera failed to bind the explant basement 
membrane zone. Immunoblotting of bullous pemphigoid 
sera showed five of seven indirect immunofluorescence_ 
negative bullous pemphigoid sera to bind high - molecular 
weight and/or low-molecular weight bullous pemphigoid 
antigens from epidermal extracts. We conclude that the skin 
explant culture system is a very sensitive method for the 
detection of bullous pemphigoid antibodies in all bullous 
pemphigoid sera. Key words: bullous pemphigoid/skin ex-
plant culture/immunofluorescence/immunoblotting. ] In-
vest DerrnatoI101:624-627, 1993 
intracellular in the HD attachment plaque and shares molecular 
similarity to desmoplakins I and II . The low - molecular weight BP 
antigen may be a transmembrane molecule that is located in both 
the HD plaque and the lamina lucida [5,12-14]. Epidermolysis 
bullosa acquisita (EBA) is another subepidermal bullous disease that 
may share clinical, histologic, and immunopathologic features with 
BP. About 50% of patients have circulating anti-BMZ antibodies 
that bind the lamina densa and sub-lamina densa regions, and that 
identify collagen VII, a component of anchoring fibrils [15-17]. 
Two questions remain unanswered. First, in spite of the consist-
ent in vivo deposition oflgG and C3 in patients' skin, only 70% have 
detectable circulating BP IgG by standard lIF using monkey esoph-
agus or intact human skin as substrate. The percentage is higher 
(approximately 90%) when salt-split human skin is used. Second, 
BP disease activity does not correlate strongly with the presence or 
titer ofBP IgG as detected by standard lIF [18,19]. These observa-
tions may raise doubt about the pathogenic role of the routinely 
"detectable" BP IgG in the induction of BP lesions. The present 
study was designed to search for circulating BP antibodies in BP sera 
that were negative by standard lIF. 
MATERIALS AND METHODS 
Patient's Sera Sera from seven patients with the clinical, histologic, and 
direct immunofluorescence (DIF) features of BP that were negative by TlF 
(on monkey esophagus and salt-split normal human skin) were used. In 
addition, sera from four BP patients with positive lIF were used as positive 
controls. IlF-negative serum from one patient with herpes (pemphigoid) 
gestationis (HG) was also used. All BP and HG sera were obtained from the 
Clinical Immunodermatology Laboratory at the University of Cincinnati, 
Ohio. Sera are obtained at the time of patient presentation as part of the 
standard diagnosis work-up. Accordingly, all patients had active disease. 
Eight EBA sera were also tested. Three had anti-BMZ antibodies and five 
0022-202X/93/S06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. 
624 
VOL. 101, NO. 4 OCTOBER 1993 
Table 1. Skin Explant Immunofluorescence and 
W estern Blotting for Bullous Pemphigoid 
and Epidermolysis Bullosa Acquisi ta Sera 
Positive 
Sera Number Skin Explant 
BP IIF positive 4 
BP JIF negative 7 
I-l G I1F negative 1 
EBA UF positi~e 3 
EBA IIF negative 5 
Negative controls 2 
-. high- molecular weight BP antigen . 
• low- molecu lar weight BP antigen. 
e ND, not done. 
J NB, no bands. 
4/4 
7/7 
1/1 
3/3 
0/5 
0/2 
Western Blotting 
H' (I), Lb (I), 
H&L (1), ND' (1) 
H&L (3), L (2), NBJ (2) 
ND 
ND 
NO 
NB (2) 
ere negative by !IF using salt-spl it human skin. Five of the EBA sera were 
W ovided by Dr. W. Ray Gammon (Chapel Hi ll , North Carolina). Two 
~~rmal human sera were used as negative controls (Table I) . 
skin Fresh skin was obtained from breast reduction surgery of a 17 -year-
old white female, cut Into small (2-x-4- mm) samples 111 medlllm 199 (M 
199) . 
bnmunoBuorescence Studies Three. or fou~ skin explan~s were incu-
bated with each of the above sera at 1 : 5 dtlutlon 111 M 199 at 4 C for 48 h as 
described previously [5]. Explants were then washed three times 111 M 199 fo r 
60 min each, and then frozen. Cryosections were lIlcubated With fluorescem 
. othiocyanate (FITC}-conjugated polyclonal antihuman IgG. Explants in-
IS bated wi th BP and HG sera were also incubated with FITC-labeled 
cu onodonal antihuman IgG antibodies that are monospecific for each of the 
fo ur IgG subclasses (I , II , III , and IV) for 30 min, followed by three 10-min 
washes in phosphate-buffered sal111e (PBS). 
Western Blotting Westcrn blotting was pcrformcd as dcscribedyrcvi-
usly [9]. All seven !IF-negative BP sera, three of the four IIF-posltlve BP 
o ra and [wo normal human sera were tested. Skin was obtained from human 
:~rgical specimens. The epidermal extract was subjectcd to a 6% polyacryl-
amide gel. 
RESULTS 
Immunofluorescence All seven IIF-negative BP sera (Fig 1), 
one I1F-negative HG serum, and the four IlF-positive BP sera had 
IgG that bound the skin BMZ in a moderate to intense fashion. The 
predominant subclass deposited by all BP sera was IgG 4 , followed by 
IgG
I
• IgG2 and IgG3 were weaker and more variably expressed. 
There was no IgG binding by either of the two normal human sera 
(Table I). Incubation of normal human skin sectio ns withthe serum 
shown in Fig 1 (standard IIF) failed to reveal any b1l1d1l1g to the 
BMZ (Fi g 2). No binding was detected in sections incubated with 
the serum for 48 h. With such prolonged incubations the back-
ground nonspecific fluorescence was very intense, thus masking any 
potential specific binding. Extensive washing of the sections to de-
crease the intensiry of fluorescence was unsuccessful and often led to 
the loss of the sections. EBA sera that were posi tive by standard IIF 
revealed binding to th e BMZ of skin explants, whereas negative 
EBA sera failed to bind the BMZ (Table I). 
Irnmunoblotting Of the three IIF-positive BP sera, one identi-
fied only the high - molecular weight BP antigen, another identi-
fied only th e low- molecular weight BP antigen, and the third 
identified both antigens. Of the seven IIF-negative BP sera, two 
identified only the low-molecular weight BP antigen, three iden-
tified both anti gens, and two did not identify any proteins (Fig 3, 
Table I) . All sera that identified the low - molecular weight BP 
antigen also identified a slightly lower- molecular weight protein 
that represents a breakdown product of the low - molecular weight 
BP a ntigen . N o binding was seen with normal human sera. 
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Figure 1. Demonstration of anti-BMZ antibodies by the skin culture 
method in a bullous pemphigoid serum that is negative by standard indirect 
immullofluorescence. Human skin explant was incubated with the seru m at 
4·C for 48 h and washed. Frozen sections were incubated with fluorescein 
isothiocyanate-labelcd antihuman IgG . Intense binding of IgG to the base-
ment membrane is seen. Bar, 40 Ji. 
DISCUSSION 
W e anticipated that all BP sera would have antibodies to the lamina 
lucida/extracel lular BP an tigen because all BP patients have ill Il illO 
bound immune deposits in the lami na lucida that most likely are 
derived from the circulation. Indeed, al l BP sera tested that are 
negative by standard IIF had anti-BMZ antibodies as shown by th e 
continuous linear binding to the BMZ of skin explants. The mor-
phology of the BMZ bind ing was simi lar to that observed in DIF 
Figure 2. Standard indirect immunofluorcscence using the same serum as 
in Fig 1. Normal human skin cryosections were incubated with bullous 
pemphigoid serum (see Fig I) for several hours, washed, then incubated with 
fluorescein isoth iocyanate- Iabcled antih uman IgG. No evidence of binding 
to the basement membrane zone is seen. A rrows, basement mcmbrane zonc. 
Bar, 25 Ji. 
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Figure J. Demonstration of antibody binding to bullous pemphigoid (BP) 
antigen in BP sera that are negative by standard indirect immunofluores-
cence (IIF). Western blotting of normal human epidermal extract was per-
formed using IlF-positive BP sera (fall es 3 -5), IIF-negative BP sera (fall es 
6 - 12), and normal human serum (fall es 1,2). Sera in fall es 3, 6, 7, and 9 bind 
both high - as wel l as low - molecular weight BP antigens (arrows) . The 
serum in fatl e 4 binds only the high - molecular weight BP antigen. Sera in 
falles 5, 8, and 10 bind the low - molecular weight BP antigen only. Sera in 
fa lles 11 and 12 as well as normal human sera (fall es 1 and 2) fai l to bind BP 
antigen. Opal arrow points to a band that is a breakdown product of the 
low- molecular weight BP antigen. 
specimens of patients with BP. Indeed, when skin explants preincu-
bated with BP sera were treated with 1 M NaCI for 48 h to induce 
dermal-epidermal separation, IgG binding was detected on the epi-
dermal side of the separation (data not shown), similar to findings in 
BP patients' skin. It is interesting to note that the HG serum that is 
negative by lIF had detectable anti-BMZ antibodies under explant 
conditions. HG is considered to be a variant of pemphigoid. 
The observed binding could not represent bimling to intracellular 
HD because basal cell viability is maintained under the explant 
conditions [5] . Indeed, indirect immunoelectron microscopy studies 
performed using skin explants consistently revealed antibody bind-
ing to the lamina lucida l5,7]. The reason for the increased sensitiv-
ity of the explant culture method compared to the standard IIF is not 
clear. As hypothesized previously [5] , the amount of antibody to the 
extracellular lamina lucida BP antigen may be low. Alternatively, 
the amount of extracellular antigen may be low and thus optimal 
antigen-antibody interaction may need prolonged incubation. 
The pathogenic role ofBP antibodies has been suggested but not 
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confirmed. The significance of BP antibodies against the low-
molecular weight antigen versus those against the high - molecular 
weight ant igen has not been determined. Additionally, the signifi-
cance of BP antibodies against the HD versus those against the 
lamina lucida is not clear at present. Intuitively, antibodies against 
the lamina lucida are likely more significant in the disease patho-
genesis, because they are detected in patients' skin lesions. If future 
studies confirm this possibility, our findin gs may explain why BP 
disease activity does not correlate with the presence or titer of circu-
lating antibodies [18,19]. These antibodies , as detected by standard 
lIF , are directed primarily against intracellular antigen. It will be 
interesting to study the correlation of BP disease activity with the 
titer of anti-lamina lucida antibodies. Such studies could be per-
formed using the skin explant culture system. If that correlation is 
positive, it would support the pathogenicity of anti-lamina lucida 
antibodies. 
of particular interest is the finding that five of the seven IIF-ne-
gative BP sera identified the lower- molecular weight BP antigen 
with moderate to marked intensity compared to the higher-
molecular weight BP antigen. This may reflect the preferential or 
exclusive binding of the IIF-negative sera to the lamina lucida that 
appears to contain only the lower-molecular weight BP antigen 
[14]. The reason that negative EBA sera, unlike negative BP sera, 
fail to bind the BMZ of the skin explant system is unclear at present. 
In summary, we have shown that all tes ted sera from patients 
with BP (and HG) that are negative by standard lIF (and some by 
immunoblotting) contain predominantly IgG4 antibodies that bind 
the BMZ (lamina lucida) and identify the same proteins identified 
by BP sera with positive IIF. Therefore, such sera should be used 
more often in the various areas of research about BP because the 
predominant or exclusive antibodies in these sera are the potentially 
pathogenic anti - lamina lucida antibodies. 
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